15 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
, it shall be deemed to be followed by the words “without limitation”;
(e) references herein to any gender shall include each other gender;
(f
DEF 14A
sct582bu8wpfg8bo
25 Apr 22
Definitive proxy
5:28pm
424B4
plf7xc um
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
EX-10.4
1nyf7gh4eq
19 Jul 21
IPO registration
7:02am
S-1
sqr002kk
19 Jul 21
IPO registration
7:02am
DRS/A
6zn6nmrs3xpd pc
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
8un6a4j5syabtze8
7 May 21
Draft registration statement
12:00am
DRS
EX-10.4
y2r0dewv
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next